BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9810892)

  • 1. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical sensitizers in alopecia areata.
    McMichael AJ; Henderson RL
    Dermatol Nurs; 2004 Aug; 16(4):333-6. PubMed ID: 15471045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of alopecia areata with squaric acid dibutylester.
    Hill ND; Bunata K; Hebert AA
    Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymopentin in the treatment of severe alopecia areata.
    Tosti A; Manuzzi P; Gasponi A
    Dermatologica; 1988; 177(3):170-4. PubMed ID: 3049174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia areata: more on topical sensitizers.
    Orecchia G; Marelli MA; Perfetti L; Rabbiosi G
    Dermatologica; 1990; 180(2):57-9. PubMed ID: 2311796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
    Miranda A; Mato F; QuiƱones PA
    Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
    Orecchia G; Malagoli P; Santagostino L
    Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Ajith C; Gupta S; Kanwar AJ
    J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical immunotherapy with squaric acid dibutylester: unusual hair pigmentary changes in two cases of alopecia areata.
    Mastrolonardo M; Diaferio A
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):186. PubMed ID: 12046838
    [No Abstract]   [Full Text] [Related]  

  • 12. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone.
    Perret CM; Steijlen PM; Zaun H; Happle R
    Dermatologica; 1990; 180(1):5-7. PubMed ID: 2137800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioedema After Squaric Acid Treatment in a 6-Year-Old Girl.
    Chen CA; Carlberg V; Kroshinsky D
    Pediatr Dermatol; 2017 Jan; 34(1):e44-e46. PubMed ID: 27699860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of hair regrowth in alopecia areata.
    Orecchia G; Rabbiosi G
    Dermatologica; 1988; 176(5):270-2. PubMed ID: 3384153
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Chua SH; Goh CL; Ang CB
    Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical immunotherapy in the treatment of chronic severe alopecia areata.
    Shapiro J
    Dermatol Clin; 1993 Jul; 11(3):611-7. PubMed ID: 8365043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squaric acid dibutylester in alopecia areata: is discomfort really necessary?
    Orecchia G; Rabbiosi G
    J Am Acad Dermatol; 1987 Apr; 16(4):876. PubMed ID: 3571551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.